Trial
NCT02348255
NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, Davis
Collaborators
National Cancer Institute (NCI); NovoCure Ltd.
Condition
Adult Brain Glioblastoma
Intervention
Electric Field Therapy
Why stopped
Poor Accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-09